Literature DB >> 26137212

Evaluation of pulmonary function changes in children with type 1 diabetes mellitus in Upper Egypt.

Ismail L Mohamad1, Khaled Saad2, Ali Abdel-Azeem3, Sherif A A Mohamed3, Hisham A K Othman4, Khaled A Abdel Baseer5, Ahmad F Thabet6, Amira A El-Houfey7.   

Abstract

BACKGROUND: Diabetes mellitus is a leading cause of morbidity and mortality among children across the world and is responsible for a growing proportion of global healthcare expenditure. However, limited data are available on lung dysfunction in children with diabetes. AIM: The aim of this study was to evaluate the pulmonary function changes in children with type 1 diabetes mellitus (T1DM).
METHODS: We studied 60 children with T1DM (mean age 10.5 ± 2.32 years; disease duration 2.45 ± 0.6 years, and 50 healthy control children (mean age 9.9 ± 2.5 years). Spirometry was performed for all individuals to measure forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, and peak expiratory flow rate (PEFR). Glycemic control was assessed on the basis of glycated hemoglobin (HbA1c), with HbA1c values <8% considered to indicate good glycemic control, and HbA1c values ⩾8% to indicate poor control.
RESULTS: There was significant reduction in all spirometeric parameters in diabetic children in comparison with healthy control children. Children with poor glycemic control had significant impairment in lung functions compared with those with good glycemic control.
CONCLUSIONS: T1DM in children leads to impairment of lung functions and this impairment increases with poor glycemic control.

Entities:  

Keywords:  Egypt; children; pulmonary function; spirometry; type 1 diabetes mellitus

Year:  2015        PMID: 26137212      PMCID: PMC4480553          DOI: 10.1177/2042018815580514

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  18 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Lung function abnormalities in children with type I diabetes.

Authors:  R van Gent; H J L Brackel; M de Vroede; C K van der Ent
Journal:  Respir Med       Date:  2002-12       Impact factor: 3.415

3.  Association between glycemic state and lung function: the Framingham Heart Study.

Authors:  Robert E Walter; Alexa Beiser; Rachel J Givelber; George T O'Connor; Daniel J Gottlieb
Journal:  Am J Respir Crit Care Med       Date:  2003-03-15       Impact factor: 21.405

4.  Lung functions in poorly controlled type 1 Saudi diabetic children and adolescents.

Authors:  Muslim M Al-Saadi; Sultan A Meo; Abdul M Al-Drees; Sarar Mohamed; Shaffi A Shaikh; Khalid Al-Rubeaan
Journal:  Saudi Med J       Date:  2011-08       Impact factor: 1.484

5.  Pulmonary function in patients with diabetes mellitus.

Authors:  C A Benbassat; E Stern; M Kramer; J Lebzelter; I Blum; G Fink
Journal:  Am J Med Sci       Date:  2001-09       Impact factor: 2.378

6.  Experimental diabetes and the lung. II. In vivo connective tissue metabolism.

Authors:  A F Ofulue; W M Thurlbeck
Journal:  Am Rev Respir Dis       Date:  1988-08

7.  Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome.

Authors:  J Rosenecker; R Höfler; G Steinkamp; I Eichler; C Smaczny; M Ballmann; H G Posselt; J Bargon; H von der Hardt
Journal:  Eur J Med Res       Date:  2001-08-27       Impact factor: 2.175

8.  Lung function in children with diabetes mellitus.

Authors:  Salvatore Cazzato; Filippo Bernardi; Silvana Salardi; Davide Tassinari; Ilaria Corsini; Luca Ragni; Alessandro Cicognani; Emanuele Cacciari
Journal:  Pediatr Pulmonol       Date:  2004-01

9.  Reduced vital capacity in insulin-dependent diabetes.

Authors:  R A Primhak; G Whincup; J N Tsanakas; R D Milner
Journal:  Diabetes       Date:  1987-03       Impact factor: 9.461

Review 10.  Current strategies for evaluating, monitoring, and treating type 2 diabetes mellitus.

Authors:  Jeff Unger
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

View more
  2 in total

1.  Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model.

Authors:  Jinshui He; Chaowei Lian; Yanling Fang; Jinzhi Wu; Jianning Weng; Xiaoling Ye; Huowang Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.

Authors:  Anas Elgenidy; Ahmed K Awad; Khaled Saad; Mostafa Atef; Hatem Helmy El-Leithy; Ahmed A Obiedallah; Emad M Hammad; Faisal-Alkhateeb Ahmad; Ahmad M Ali; Hamad Ghaleb Dailah; Amira Elhoufey; Samaher Fathy Taha
Journal:  Pediatr Res       Date:  2022-08-11       Impact factor: 3.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.